British Journal of Cancer · 2006 · 123 citations · 34 references
MedicineMolecular BiologyOncologyCancer GeneticsMolecular OncologyNeoplasiaBorderline Ovarian TumorsCancer Molecular PathologyMolecular Classification Of TumorsOvarian CancerOvarian PathologyTumor ClassificationHistopathological SubtypesMalignant Ovarian NeoplasmsMalignant ProgressionMicroarray AnalysisMucinous Ovarian TumorsOvarian Cancer BiomarkersOvarian Tumor BiomarkersPrimary Ovarian Carcinoma
Mucinous epithelial ovarian cancers (MOC) are clinically and morphologically distinct from the other histological subtypes of ovarian cancer. To determine the genetic basis of MOC and to identify potential tumour markers, gene expression profiling of 49 primary ovarian cancers of different histological subtypes was performed using a customised oligonucleotide microarray containing >59 000 probesets. The results show that MOC express a genetic profile that both differs and overlaps with other subtypes of epithelial ovarian cancer. Concordant with its histological phenotype, MOC express genes characteristic of mucinous carcinomas of varying epithelial origin, including intestinal carcinomas. Differences in gene expression between MOC and other histological subtypes of ovarian cancer were confirmed by RT-PCR and/or immunohistochemistry. In particular, galectin 4 (LGALS4) was highly and specifically expressed in MOC, but expressed at lower levels in benign mucinous cysts and borderline (atypical proliferative) tumours, supporting a malignant progression model of MOC. Hence LGALS4 may have application as an early and differential diagnostic marker of MOC.
34
Ingrid Lönnstedt · 2001 · 672 citations
Sorin Drăghici, Purvesh Khatri, Rui Pires Martins et al. · Genomics · 2003 · 584 citations